InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: loanranger post# 252660

Wednesday, 12/26/2018 12:10:05 PM

Wednesday, December 26, 2018 12:10:05 PM

Post# of 403033
Correct, LR. OM shows up with treatment (even without radiation) of several cancers, not only in HNC. Trials using HNC subjects happens to be the easiest (limited treatment time plus very high incidence of SOM) route to approval. Also, after approval nothing prevents attending physicians from prescribing the drug off label to treat OM occurring with other than HNC subjcets.

The other and nitpicky (there is some interpretational disagreement around) point: Oral brilacidin has minimal systemic absorption so it doesn't have effect on what happens deeper in human tissue (IV version would). Hence and strictly speaking, oral brilacidin is for treatment of oral mucositis, not for prevention of it. Well, yeah, it can prevent OM from developing into severe OM, and can snub out instances of mucositis before they are detected in weekly or bi-weekly examination, but principally it treats condition that has already emerged.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News